Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for osteonecrosis of the jaw
ACTRN12612000950864Phase 3Completed
- Sponsor
- University of Melbourne
- Start
- Nov 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteonecrosis of the jaw (ONJ) comparing Teriparatide arm with Placebo arm (2 arms). Primary endpoints: Clinical staging of osteonecrosis of the jaw at 52 weeks and Radiological staging of osteonecrosis of the jaw at 52 weeks. Started Nov 2012; status: completed.
02
Drugs
teriparatide
03
Conditions
osteonecrosis of the jaw (ONJ)
Beyond the preview
Go deeper on ACTRN12612000950864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000950864.